about
Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.Reliability of four experimental mechanical pain tests in children.Apparent cerebral cytochrome aa3 reduction during cardiopulmonary bypass in hypoxaemic children with congenital heart disease. A critical analysis of in vivo near-infrared spectrophotometric data.Specific strength training compared with interdisciplinary counseling for girls with tension-type headache: a randomized controlled trial.Test-retest repeatability of strength capacity, aerobic power and pericranial tenderness of neck and shoulder muscles in children - relevant for tension-type headacheIdiopathic neuralgic amyotrophy in children. Case report, 4 year follow up and review of the literature.Sequence analysis of SLITRK1 for var321 in Danish patients with Tourette syndrome and review of the literature.Chromosomal rearrangements in Tourette syndrome: implications for identification of candidate susceptibility genes and review of the literature.Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study.Reduced neck-shoulder muscle strength and aerobic power together with increased pericranial tenderness are associated with tension-type headache in girls: A case-control study.Noninvasive brain monitoring with near infrared spectroscopy in newborn infants.Pain sensitivity and pericranial tenderness in children with tension-type headache: a controlled studyThe presence of attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder worsen psychosocial and educational problems in Tourette syndrome.Becoming a client of the Danish social service system increases stress in parents of disabled infants.Capillary recruitment for preservation of cerebral glucose influx in hypoglycemic, preterm newborns: evidence for a glucose sensor?A t(3;9)(q25.1;q34.3) translocation leading to OLFM1 fusion transcripts in Gilles de la Tourette syndrome, OCD and ADHD.Risk factors of ophthalmic disorders in children with developmental delay.[Near infrared spectrophotometry--a non-invasive, continuous method for monitoring of cerebral status in newborn infants]The presence of comorbidity in Tourette syndrome increases the need for pharmacological treatment.[Tourette syndrome. Genetics, neuroanatomy and neurotransmitters].Longitudinal Magnetic Resonance Imaging (MRI) Analysis of the Developmental Changes of Tourette Syndrome Reveal Reduced Diffusion in the Cortico-Striato-Thalamo-Cortical Pathways.Cerebroelectrical depression following surfactant treatment in preterm neonates.Study of medication-free children with Tourette syndrome do not show imaging abnormalities.Altered pain perception in children with chronic tension-type headache.Microduplication of 15q13.3 and Xq21.31 in a family with Tourette syndrome and comorbidities.Predictive factors for familiality in a Danish clinical cohort of children with Tourette syndrome.Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort.Genetic predisposition increases the tic severity, rate of comorbidities, and psychosocial and educational difficulties in children with Tourette syndrome.When resources get sparse: a longitudinal, qualitative study of emotions, coping and resource-creation when parenting a young child with severe disabilities.Visual dysfunctions and ocular disorders in children with developmental delay. II. Aspects of refractive errors, strabismus and contrast sensitivity.Computer animated relaxation therapy in children between 7 and 13 years with tension-type headache: a pilot study.Limited knowledge of Tourette syndrome causes delay in diagnosis.[Clinical aspects of Tourette syndrome].[Developmental delay in children. Prevalence, aetiology and examination--a situation report].Visual dysfunctions and ocular disorders in children with developmental delay. I. prevalence, diagnoses and aetiology of visual impairment.[Tic suppression is a new evidence-based non-farmacological treatment of chronic tic disorder].Neonatal intensive care: an obvious, yet difficult area for cerebral near-infrared spectroscopyCerebral blood flow and left ventricular output in spontaneously breathing, newborn preterm infants treated with caffeine or aminophyllineCerebral blood flow and plasma hypoxanthine in relation to surfactant treatmentEstimation of Cerebral Venous Saturation in Newborn Infants by Near Infrared Spectroscopy
P50
Q34356769-30B86322-8D13-4E1D-AB5C-6635254A459AQ36600447-2D143CB7-CCD6-4C2B-909B-2E684F50CB26Q36718632-86248F40-5686-471F-A81E-29FFA621A22AQ36887554-F6A1BBCF-57C5-4D84-B492-5B34D9F43187Q37164467-145556F6-A0BA-44E1-A094-9503AC299552Q37720072-B276C029-5CD2-4912-B108-8D387B5ADA97Q38092975-FC1D0C2E-2AA5-4C86-B930-080203C60BD6Q38132671-2025F059-6989-4413-96E1-6E16C7DBDB3BQ38881611-9A4D1350-810F-4512-8E42-9F27595F184AQ39291930-5AA5404D-149B-4ADE-8EE6-81F4E6269998Q41116098-6709031E-699C-4D0E-A430-D58E6963A1B8Q42099945-D40510E7-1AD3-402F-83B1-39C78BA852C1Q43604990-88A2C689-C7CC-4003-B77C-F994635643CEQ45030396-EB9C1697-D30D-4D31-B0C7-4706812F1091Q45047231-A6E22E94-B675-4A86-8452-AA0101023E54Q45063676-66615D69-B474-4BAF-BE8F-E558B525003BQ45279116-A7C168E2-4E77-4996-B1D5-BCEA60E14F26Q45351438-C749A3F0-F243-40AA-82AF-D2A3AC119029Q45983820-3F7644B2-BB5E-43C5-99A7-2EB5E1F6BCC7Q46398564-B9EF8297-4790-483B-A572-D78FB3B1A453Q48402208-E9772678-F632-4511-AA95-55E848B23701Q48497775-834FDFB5-C228-46D8-94D1-2C3494A2694AQ48761954-3A682E4D-09E9-49A6-86DB-02748DD8C1A0Q49366344-213FA6D9-E0A5-416F-84DE-E9D5F1F1D698Q50311568-3FA8D439-2DBF-4036-9B0D-1E00EE85AB31Q50551288-1AB02ACD-D5C2-4759-96F7-F08847B2B26EQ50560937-A54BBBBE-FADE-4468-8A48-22553AA9AD2EQ50638781-41486A3E-D3B0-4C90-A4A5-DD73D570DF68Q50652630-41C74289-6895-41E6-9E71-30009840AB9AQ50798929-A913823A-8784-4B86-A002-B3D46D297881Q51847618-3D6F5755-080D-4085-B574-06032D06F8B9Q51887806-ADED8B9F-C96B-4A57-9DF6-DCF0C1AC440EQ51949980-918E4F45-3B5B-437E-9D11-E22CA8E0BEA1Q51982430-650744AD-3B29-4AF2-9DA6-9BD4E5810309Q51995794-CF5AC07E-7ED7-461A-A91D-52E29449A96EQ53461961-B1704B48-C073-44C6-A100-B606CFEAED75Q57198874-24DB6AF8-312F-4F00-A26B-8AD385F93CBCQ57198894-C3733505-1902-41E6-81B5-D4DFA170618BQ57198897-1B11B923-89B4-4EAE-BF15-D4ACE9CBB77EQ57198904-CE47AE94-3B42-4D97-B43F-5E3E269DEFE8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Liselotte Skov
@ast
Liselotte Skov
@en
Liselotte Skov
@es
Liselotte Skov
@nl
type
label
Liselotte Skov
@ast
Liselotte Skov
@en
Liselotte Skov
@es
Liselotte Skov
@nl
prefLabel
Liselotte Skov
@ast
Liselotte Skov
@en
Liselotte Skov
@es
Liselotte Skov
@nl
P106
P108
P31
P496
0000-0002-2137-0735